Skip to content Skip to footer
Subscribe Now
Viewpoints_Dr. Susana Banerjee
VIEWPOINTS
Dr. Susana Banerjee, Medical Oncologist at The Royal Marsden Shares Insights from the SOLO-1 P-III Trial of Lynparza in Patients with BRCA Mutated Ovarian Cancer
Shots:Dr. Susan talked about the results from the SOLO-1 P-III trial of Lynparza in patients with BRCA mutated (BRCAm) newly diagnosed advanced ovarian cancer presented at ESMO’22Dr. Susan also spoke about the overall survival of this 7-year follow-up study.The 7-year follow-up of SOLO-1 showed that olaparib provided a clinically meaningful improvement in OS…
November 14, 20220Comments
Prescription Drugs Top 20 2021
TOP 20
Top 20 Prescription Drugs Based on 2021 Total Revenue
Shots:The pharmaceutical companies have shown continual efforts towards developing enhanced and innovative treatment options to address the unmet needs of patients with disease eradication being the goal of developing these treatmentsAdvancements in cellular and molecular biology have increased the possibilities for generating new pharmaceutical products imposing major impacts on the prevention, diagnosis, and…
November 10, 20220Comments
Viewpoints_Dr. Bill La Via
VIEWPOINTS
Dr. Bill La Via, Medical Director at Sanofi Shares Insights from the Findings that Support the Need of Protecting Infants from Respiratory Syncytial Virus (RSV)
Shots:Bill spoke about Respiratory Syncytial Virus and how it can severely affect infants' healthBill also talked about the 14 studies on RSV published in the Journal of Infectious Diseases (JID)The interview gives an understanding of how Sanofi’s vision to develop innovative solutions to help reduce the burden of RSV on infants, families,…
November 9, 20220Comments
Viewpoints_Simon Portsmouth
VIEWPOINTS
Simon Portsmouth, VP, Head of Clinical Development, Shionogi Shares Insights from the New Data on an Antibiotic to Treat Bacterial Infections
Shots:Simon spoke about the new data on FETROJA (cefiderocol), an antibiotic for the treatment of serious Gram-negative (highly resistant) bacterial infectionsHe also talked about Shionogi’s agreement with GARDP & CHAI for the manufacturing and commercialization of cefiderocol in different countriesThe interview summarizes how Shionogi is advancing by developing medicines to treat serious…
November 7, 20220Comments
Viewpoints_Martin Kilsgård
VIEWPOINTS
Martin Kilsgård, Head of Product at Trialbee, Shares Insights from the Launch of Trialbee Honey™ Analytics at DPHARM 2022
Shots:Martin gave a detailed view of the newly launched Honey Analytics module associated with the Trialbee Honey™ platformHe also talked about the how Trialbee Honey platform will help in the screening and recruiting of patients specifically in remote areasThe interview gives a profound understanding of how Trialbee is developing real-time monitoring modules…
November 2, 20220Comments
Viewpoints_Natalie Shiff
VIEWPOINTS
Natalie Shiff, Associate Medical Director, Janssen Rheumatology Shares Insights from the FDA Approval of Stelara to Treat Pediatric Patients with Active Psoriatic Arthritis
Shots:Natalie spoke about the study design and key findings from the P-III study evaluating Stelara for the treatment of pediatric patients with active psoriatic arthritisShe also spoke about the patient support program that is executed by Janssen to support patients to get Stelara The interview gives an understanding of how Janssen is advancing…
October 31, 20220Comments